Who are Lipid Emulsions, Intravenous's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Lipofundin MCT 20%, Amino acid solution, Lipid Emulsion, Intravenous, SMOFlipid + Omegaven.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/lipid-emulsions-intravenous.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Lipid Emulsions, Intravenous — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lipid Emulsions, Intravenous (Lipid Emulsions, Intravenous) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Parenteral nutrition supplement. Area: Nutrition support / Critical care.

marketed Parenteral nutrition supplement Nutrition support / Critical care Small molecule Live · refreshed every 30 min

Target snapshot

Lipid Emulsions, Intravenous (Lipid Emulsions, Intravenous) — Stanley Dudrick's Memorial Hospital. Lipid emulsions provide essential fatty acids and calories intravenously to patients unable to receive adequate nutrition orally or enterally.

Comparator set (4 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Lipid Emulsions, Intravenous TARGET	Lipid Emulsions, Intravenous	Stanley Dudrick's Memorial Hospital	marketed	Parenteral nutrition supplement
Lipofundin MCT 20%	Lipofundin MCT 20%	B. Braun Melsungen AG	marketed	Lipid emulsion; parenteral nutrition supplement
Amino acid solution	Amino acid solution	B.P. Koirala Institute of Health Sciences	marketed	Parenteral nutrition supplement
Lipid Emulsion, Intravenous	Lipid Emulsion, Intravenous	Aya Sabry Mohamed Mohamed	marketed	Parenteral nutrition supplement
SMOFlipid + Omegaven	SMOFlipid + Omegaven	General University Hospital, Prague	marketed	Lipid emulsion / Parenteral nutrition supplement

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Parenteral nutrition supplement class)

Aya Sabry Mohamed Mohamed · 1 drug in this class
B.P. Koirala Institute of Health Sciences · 1 drug in this class
Stanley Dudrick's Memorial Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Lipid Emulsions, Intravenous — Competitive Intelligence Brief. https://druglandscape.com/ci/lipid-emulsions-intravenous. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab